Get started
Author

Yingmeng Yao

USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy
2024 · Haiou Li, Yishuang Sun, et al. · Proceedings of the National Academy of Sciences · 136
PDF
Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy
2023 · Haisheng Yu, Jing Liu, et al. · Cell chemical biology · 90
ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy
2023 · Xiangling Xiao, Jie Shi, et al. · Nature Communications · 88
PDF
PD-1 regulation in immune homeostasis and immunotherapy
2024 · Minling Gao, Jie Shi, et al. · Cancer Letters · 76
UFL1 ablation in T cells suppresses PD-1 UFMylation to enhance anti-tumor immunity
2024 · Chuan He, Xixin Xing, et al. · Molecular Cell · 72
The epitranscriptional factor PCIF1 orchestrates CD8+ T cell ferroptosis and activation to control antitumor immunity
2025 · Bolin Xiang, Meiling Zhang, et al. · Nature Immunology · 34
USP2 inhibition unleashes CD47-restrained phagocytosis and enhances anti-tumor immunity
2025 · Panpan Dai, Yishuang Sun, et al. · Nature Communications · 30
PDF
Targeting the TRIM21-PD-1 axis potentiates immune checkpoint blockade and CAR-T cell therapy
2025 · Jie Shi, Zijian Zhang, et al. · Molecular Therapy · 26
Targeting the UFL1-PARP1 axis amplifies anti-tumor immunity
2025 · Wenjing Song, Chuan He, et al. · Cell Reports · 8
Destruction of VISTA by TRIM25 ablation in T cells potentiates cancer immunotherapy
2025 · Yishuang Sun, Zijian Zhang, et al. · Cell Research · 6
CDK10 suppresses nucleic acid sensors-mediated antitumor immunity
2026 · Gaoshan Xu, Fusheng Guo, et al. · Nature Cancer · 5
Energy status orchestrates YTHDF1 phase separation and tumorigenesis
2025 · Haisheng Yu, Jie Shi, et al. · Cell Reports · 2
Author Correction: ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy
2025 · Xiangling Xiao, Jie Shi, et al. · Nature Communications
PDF
Works count: 13
Citation count: 573
H-index: 8
I10-index: 8
Year
Topic
Type